Danaher Co. (NYSE:DHR) Shares Acquired by Atria Investments Inc

by · The Cerbat Gem

Atria Investments Inc lifted its holdings in shares of Danaher Co. (NYSE:DHR – Free Report) by 1.4% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The firm owned 41,462 shares of the conglomerate’s stock after buying an additional 582 shares during the period. Atria Investments Inc’s holdings in Danaher were worth $11,527,000 at the end of the most recent quarter.

A number of other hedge funds have also recently added to or reduced their stakes in the company. Field & Main Bank lifted its position in Danaher by 2.2% in the third quarter. Field & Main Bank now owns 3,442 shares of the conglomerate’s stock valued at $957,000 after purchasing an additional 75 shares during the period. Tompkins Financial Corp lifted its position in Danaher by 0.7% in the third quarter. Tompkins Financial Corp now owns 34,193 shares of the conglomerate’s stock valued at $9,506,000 after purchasing an additional 230 shares during the period. Klingman & Associates LLC lifted its position in Danaher by 11.7% in the third quarter. Klingman & Associates LLC now owns 2,017 shares of the conglomerate’s stock valued at $561,000 after purchasing an additional 211 shares during the period. Assetmark Inc. lifted its position in Danaher by 6.2% in the third quarter. Assetmark Inc. now owns 67,234 shares of the conglomerate’s stock valued at $18,692,000 after purchasing an additional 3,948 shares during the period. Finally, First Fiduciary Investment Counsel Inc. lifted its position in Danaher by 2.2% in the third quarter. First Fiduciary Investment Counsel Inc. now owns 42,055 shares of the conglomerate’s stock valued at $11,692,000 after purchasing an additional 914 shares during the period. Institutional investors and hedge funds own 79.05% of the company’s stock.

Insider Activity

In other news, SVP Georgeann Couchara sold 952 shares of the business’s stock in a transaction on Monday, August 26th. The shares were sold at an average price of $268.37, for a total transaction of $255,488.24. Following the completion of the sale, the senior vice president now directly owns 4,212 shares of the company’s stock, valued at $1,130,374.44. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 11.10% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on the stock. StockNews.com upgraded shares of Danaher from a “hold” rating to a “buy” rating in a research report on Wednesday, November 6th. TD Cowen increased their target price on shares of Danaher from $310.00 to $315.00 and gave the company a “buy” rating in a report on Wednesday, October 23rd. KeyCorp lifted their price target on shares of Danaher from $290.00 to $310.00 and gave the company an “overweight” rating in a research report on Wednesday, October 23rd. The Goldman Sachs Group lifted their price target on shares of Danaher from $225.00 to $250.00 and gave the company a “neutral” rating in a research report on Wednesday, July 24th. Finally, Evercore ISI lifted their price target on shares of Danaher from $275.00 to $278.00 and gave the company an “outperform” rating in a research report on Tuesday, October 1st. Five research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $287.16.

Get Our Latest Stock Report on Danaher

Danaher Trading Down 0.3 %

Shares of DHR opened at $245.39 on Monday. The stock has a fifty day moving average of $264.89 and a two-hundred day moving average of $260.77. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.01 and a current ratio of 1.37. The company has a market capitalization of $177.24 billion, a PE ratio of 46.83, a price-to-earnings-growth ratio of 4.55 and a beta of 0.85. Danaher Co. has a fifty-two week low of $192.35 and a fifty-two week high of $281.70.

Danaher (NYSE:DHR – Get Free Report) last issued its quarterly earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share for the quarter, beating the consensus estimate of $1.57 by $0.14. The company had revenue of $5.80 billion during the quarter, compared to the consensus estimate of $5.59 billion. Danaher had a return on equity of 10.62% and a net margin of 16.39%. Danaher’s revenue was up 3.1% on a year-over-year basis. During the same period in the previous year, the firm posted $2.02 EPS. As a group, analysts forecast that Danaher Co. will post 7.51 EPS for the current year.

Danaher Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, October 25th. Shareholders of record on Friday, September 27th were issued a $0.27 dividend. The ex-dividend date of this dividend was Friday, September 27th. This represents a $1.08 annualized dividend and a yield of 0.44%. Danaher’s dividend payout ratio (DPR) is presently 20.61%.

Danaher Company Profile

(Free Report)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Read More